These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1409374)

  • 21. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
    Roy SD; Manoukian E
    J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrostatic charge characteristics of jet nebulized aerosols.
    Kwok PC; Trietsch SJ; Kumon M; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):149-59. PubMed ID: 20500092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the predicted time-concentration profile of serum tulobuterol in human after transdermal application.
    Nakamura A; Mori D; Tojo K
    Chem Pharm Bull (Tokyo); 2012; 60(3):300-5. PubMed ID: 22382408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of organ availability by sequential and simultaneous analyses: intestinal conjugative metabolism impacts on intestinal availability in humans.
    Mizuma T; Kawashima K; Sakai S; Sakaguchi S; Hayashi M
    J Pharm Sci; 2005 Mar; 94(3):571-5. PubMed ID: 15666320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
    Kantarci G; Ozgüney I; Karasulu HY; Arzik S; Güneri T
    AAPS PharmSciTech; 2007 Nov; 8(4):E91. PubMed ID: 18181551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cotransport of estradiol and ethanol through human skin in vitro: understanding the permeant/enhancer flux relationship.
    Liu P; Kurihara-Bergstrom T; Good WR
    Pharm Res; 1991 Jul; 8(7):938-44. PubMed ID: 1924148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods.
    Borgström L; Newman S; Weisz A; Morén F
    J Pharm Sci; 1992 Aug; 81(8):753-5. PubMed ID: 1403719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of five catecholamines and terbutaline sulfate in 5% dextrose injection in the absence and presence of aminophylline.
    Newton DW; Fung EY; Williams DA
    Am J Hosp Pharm; 1981 Sep; 38(9):1314-9. PubMed ID: 7282714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of monolithic matrix patch system containing tulobuterol.
    Rhee YS; Kwon SY; Park CW; Choi NY; Byun WJ; Chi SC; Park ES
    Arch Pharm Res; 2008 Aug; 31(8):1029-34. PubMed ID: 18787793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of skin damage caused by percutaneous absorption enhancers using fractal analysis.
    Obata Y; Sesumi T; Takayama K; Isowa K; Grosh S; Wick S; Sitz R; Nagai T
    J Pharm Sci; 2000 Apr; 89(4):556-61. PubMed ID: 10737917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
    Yan G; Li SK; Higuchi WI
    J Control Release; 2005 Dec; 110(1):141-50. PubMed ID: 16289410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Polar Ion-Pairs to Control Drug Delivery to the Airways of the Lungs.
    Dutton B; Woods A; Sadler R; Prime D; Barlow DJ; Forbes B; Jones SA
    Mol Pharm; 2020 May; 17(5):1482-1490. PubMed ID: 32101010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis.
    Pikal MJ
    Pharm Res; 1990 Feb; 7(2):118-26. PubMed ID: 2308891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Continuous nebulization with terbutaline sulfate under tent inhalation. Evaluation of the efficacy in children 2 to 5 years of age in asthmatic crises].
    Lotufo JP; Ejzenberg B; Vieira S; Mukai L; Macedo H; Yamashita C; Ventura G; Baldacci ER; Okay Y
    Rev Mal Respir; 1998 Jun; 15(3):255-61. PubMed ID: 9677633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical optimization of transdermal drug delivery system of terbutaline sulfate by factorial analysis.
    Manna A; Ghosh I; Sen N; Thakur RS; Ghosh LK; Gupta BK
    Boll Chim Farm; 2000; 139(1):34-40. PubMed ID: 10829551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of bambuterol: a beta-agonist prodrug with sustained lung affinity.
    Svensson LA
    Agents Actions Suppl; 1991; 34():71-8. PubMed ID: 1686529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline.
    Borgström L; Nilsson M
    Pharm Res; 1990 Oct; 7(10):1068-70. PubMed ID: 2281038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fast-dissolving sublingual films of terbutaline sulfate: formulation and in vitro/in vivo evaluation.
    Sayed S; Ibrahim HK; Mohamed MI; El-Milligi MF
    Mol Pharm; 2013 Aug; 10(8):2942-7. PubMed ID: 23883311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of transdermal delivery of prochlorperazine.
    Obata Y; Otake Y; Takayama K
    Biol Pharm Bull; 2010; 33(8):1454-7. PubMed ID: 20686248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The determination of terbutaline in human plasma by selected ion monitoring of the t-butyldimethylsilyl ether.
    Martin LE; Oxford J; Tanner RJ; Hetheridge MJ
    Biomed Mass Spectrom; 1979 Oct; 6(10):460-1. PubMed ID: 526565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.